Evidence map›Paper›PMID 40481888›Full record

ReviewAbdominal radiology (New York)2025

Mastering esophageal cancer imaging: what radiologists need to know.

Carlo D'Alessandro, Matteo Pittacolo, Andrea De Grandis, Pietro Garzotto, Francesca Galuppini, Lucia Moletta, Elisa Sefora Pierobon, Giovanni Capovilla, Gianpietro Zanchettin, Renato Salvador and 3 more

Abstract readReview
PubMed Publisher
In one paragraph

Review in Abdominal radiology (New York), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Carlo D'AlessandroInstitute of Radiology, Department of Medicine (DIMED), University of Padova, Padova, Italy. carlo.dalessandro@studenti.unipd.it.
Matteo PittacoloDepartment of Surgical, Oncological, and Gastroenterological Sciences, University of Padova School of Medicine, Padova, Italy, Padova, Italy.
Andrea De GrandisInstitute of Radiology, Department of Medicine (DIMED), University of Padova, Padova, Italy.
Pietro GarzottoInstitute of Radiology, Department of Medicine (DIMED), University of Padova, Padova, Italy.
Francesca GaluppiniSurgical Pathology & Cytopathology Unit, Department of Medicine (DIMED), University of Padova, Padova, Italy.
Lucia MolettaDepartment of Surgical, Oncological, and Gastroenterological Sciences, University of Padova School of Medicine, Padova, Italy, Padova, Italy.
Elisa Sefora PierobonDepartment of Surgical, Oncological, and Gastroenterological Sciences, University of Padova School of Medicine, Padova, Italy, Padova, Italy.
Giovanni CapovillaDepartment of Surgical, Oncological, and Gastroenterological Sciences, University of Padova School of Medicine, Padova, Italy, Padova, Italy.
Gianpietro ZanchettinDepartment of Surgical, Oncological, and Gastroenterological Sciences, University of Padova School of Medicine, Padova, Italy, Padova, Italy.
Renato SalvadorDepartment of Surgical, Oncological, and Gastroenterological Sciences, University of Padova School of Medicine, Padova, Italy, Padova, Italy.
Michele ValmasoniDepartment of Surgical, Oncological, and Gastroenterological Sciences, University of Padova School of Medicine, Padova, Italy, Padova, Italy.
Emilio QuaiaInstitute of Radiology, Department of Medicine (DIMED), University of Padova, Padova, Italy.
Filippo CrimìInstitute of Radiology, Department of Medicine (DIMED), University of Padova, Padova, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Esophageal cancer, particularly squamous cell carcinoma (SCC) and adenocarcinoma (EAC), is a major contributor to cancer-related mortality. The different histopathologic subtypes have different pathological origins, epidemiology and prognosis. TNM staging system allows to stratify the prognosis and determine the most appropriate treatment. Surgery remains the gold standard for treating early-stage esophageal cancer, including various procedures that can adapt to the singular cases helping to reduce morbidity. However, esophagectomy remains burdened by considerable postoperative complications, such as anastomotic leakage, pleural effusion, pneumonia, acute respiratory distress syndrome, stricture formation, chylothorax, delayed gastric emptying, hiatal herniation, and reflux esophagitis. Accurate radiologic evaluation plays a crucial role in detecting, characterizing, and staging esophageal cancer, directly influencing treatment strategies. Radiological imaging is pivotal in determining patient's prognosis, both for the management of post-operative complications and for long-term follow-up. A thorough understanding of the imaging characteristics and underlying pathology is essential for improving diagnostic accuracy and guiding therapeutic decision-making.

Indexed as

AdenocarcinomaCarcinoma, Squamous CellEsophageal NeoplasmsHumansNeoplasm StagingPostoperative ComplicationsPrognosisCancerComplicationsDiagnostic imagingEsophagusStagingSurgery

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.